European Case Law Identifier: | ECLI:EP:BA:2017:T141516.20170523 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 23 May 2017 | ||||||||
Case number: | T 1415/16 | ||||||||
Application number: | 06793347.3 | ||||||||
IPC class: | A61K 39/12 A61P 31/20 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | PCV-2 Vaccine | ||||||||
Applicant name: | Intervet International B.V. | ||||||||
Opponent name: | 01 Merial Limited 02 Boehringer Ingelheim Vetmedica GmbH |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request - inventive step - (no) Auxiliary requests 1 and 2 - clarity - (no) Auxiliary request 3 - admission into proceedings - (no) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t161415eu1.html
Date retrieved: 17 May 2021